E11.3412 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, left eye

Name of the Condition

• Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, left eye

Summary

Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, left eye, is a condition where chronic high blood sugar levels cause significant damage to the retinal blood vessels, leading to advanced retinal changes without new blood vessel growth (proliferation) and fluid accumulation in the macula of the left eye. This stage is characterized by widespread retinal ischemia, intraretinal microvascular abnormalities, venous beading, and macular edema, which can impair central vision in the affected eye. The risk of progression to proliferative diabetic retinopathy or vision-threatening complications is high if not managed appropriately.

Causes

High blood sugar levels over time damage the small blood vessels in the retina, leading to severe nonproliferative diabetic retinopathy with macular edema. Prolonged hyperglycemia in type 2 diabetes triggers vascular changes, including capillary closure and retinal ischemia, which can cause fluid leakage into the macula. Metabolic factors associated with diabetes, such as advanced glycation end products and oxidative stress, contribute to this ocular complication. Insulin resistance or insufficient insulin production in type 2 diabetes sustains hyperglycemia, accelerating retinal damage and macular edema.

Risk Factors

• Poorly controlled blood glucose levels.
• Long duration of diabetes.
• Hypertension and dyslipidemia.
• Smoking.
• Obesity and sedentary lifestyle.
• Family history of diabetic retinopathy.

Symptoms

• Blurred or distorted vision in the left eye.
• Difficulty reading or recognizing faces.
• Dark spots or floaters in the visual field.
• Reduced central vision.
• Eye pain or discomfort (less common).

Diagnosis

Diagnosis involves a comprehensive eye examination, including visual acuity testing, dilated retinal examination, and optical coherence tomography (OCT) to assess macular edema. Fluorescein angiography may be used to evaluate retinal blood vessel damage and leakage. Blood glucose and HbA1c levels are measured to confirm diabetes control. The left eye is specifically evaluated to determine the extent of retinal changes and macular involvement.

Treatment Options

Treatment focuses on managing blood sugar levels and addressing retinal damage. Laser photocoagulation may be used to reduce macular edema and prevent further vision loss. Intravitreal injections of anti-VEGF agents or corticosteroids can help control macular edema. Blood pressure and lipid management are also critical. Regular follow-up with an ophthalmologist is essential to monitor progression.

Prognosis and Follow-Up

Prognosis depends on early intervention and consistent management of diabetes. With proper treatment, vision loss may be slowed or stabilized, but some impairment may persist. Regular eye exams (every 3–6 months) are recommended to detect changes. Follow-up includes monitoring visual acuity, retinal health, and response to therapies.

Complications

• Progression to proliferative diabetic retinopathy with neovascularization.
• Permanent vision loss or blindness in the left eye.
• Macular scarring or atrophy.
• Increased risk of cataracts or glaucoma.

Lifestyle & Prevention

• Maintain tight glycemic control through diet, exercise, and medication.
• Monitor blood pressure and cholesterol levels.
• Avoid smoking and limit alcohol intake.
• Protect eyes from UV light with sunglasses.
• Attend regular diabetes and eye screenings.

When to Seek Professional Help

Seek immediate care if you experience sudden vision changes, increased floaters, or eye pain in the left eye. Regular ophthalmologic evaluations are necessary for early detection and management of retinal changes.

Tips for Medical Coders

Document the specific eye (left) and the presence of macular edema to support the code E11.3412. Include details of retinal findings (e.g., ischemia, venous beading) and any treatments (e.g., laser, injections) to ensure accurate coding and reflect the clinical severity.